Results 111 to 120 of about 1,522,567 (255)

Anxiety and depressive symptoms in adults with subjective cognitive complaints: impact of the COVID-19 Pandemic

Vertex Revista Argentina de Psiquiatría
Introduction: Subjective cognitive complaints (SCC) refer to the perception of cognitive alterations in individuals with normal performance on neuropsychological tests.
Waleska Berrios, Florencia Deschle, Sofía Caporale, Guido Di Fonzo, María Cecilia Moreno, María Laura Saglio, Cecilia Cervino, Guillermo Povedano   +7 more
doaj   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial

, 2011
Natalia Bachinskaya1, Robert Hoerr2, Ralf Ihl3For the GOTADAY Study Group1Institute of Gerontology, Academy of Medical Sciences, Kiev, Ukraine; 2Clinical Research Department, Dr Willmar Schwabe Pharmaceuticals, Karlsruhe, Germany; 3Geriatric Psychiatry ...
Bachinskaya N, Ihl R, Hoerr R
core  

Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome

British Journal of Clinical Pharmacology, EarlyView.
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, Volker Auwärter   +7 more
wiley   +1 more source

Neuropsychiatric symptoms of the elderly with Alzheimer's disease and the family caregivers' distress

Revista Latino-Americana de Enfermagem
Objective: to analyze the relationship between the distress of the family caregiver and the presence of neuropsychiatric symptoms in elderly patients with Alzheimer's disease or mixed dementia. Method: a descriptive, cross-sectional study conducted in
Luana Baldin Storti, Débora Teles Quintino, Natália Michelato Silva, Luciana Kusumota, Sueli Marques   +4 more
doaj   +1 more source

Organic disorder with neuropsychiatric symptoms - case report of anti-NMDA receptor encephalitis with neuropsychiatric manifestations

, 2017
Neuropsychiatric symptoms are symptoms that caused by organic brain disorders. Multiple neuropsychiatric symptoms can occur concurrently in the course of brain related organic disorders.
Husna Zayadi
core  

Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms

, 2013
INTRODUCTION: Caring for people with dementia incurs significant stress for carers. Stress has been related to the duration of caring role, the number of weekly hours provided and severity of cognitive impairment.
McKeith, Ian, Thomas, Alan J., Ghosh-Nodyal, Arunima, Lee, David R., Mosimann, Urs   +4 more
core   +1 more source

Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu, Yang Chen, Nan Zhang, Uazman Alam, Riccardo Proietti, Tong Liu, Kang‐Yin Chen, Gregory Y. H. Lip   +7 more
wiley   +1 more source

Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: A systematic review

Dementia & Neuropsychologia
Introduction: Neuropsychiatric symptoms are frequent in Alzheimer's disease and negatively affect patient quality of life. Objective: To assess the effectiveness of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer ...
Raiana Lídice Mór Fukushima, Elisangela Gisele do Carmo, Renata do Valle Pedroso, Pollyanna Natalia Micali, Paula Secomandi Donadelli, Gilson Fuzaro Junior, Reisa Cristiane de Paula Venancio, Juliana Viola, José Luiz Riani Costa   +8 more
doaj   +1 more source

Relationships among nitrous oxide exposure, neurological injury and biomarkers

British Journal of Clinical Pharmacology, EarlyView.
Aims Recreational nitrous oxide (N2O) misuse is an increasing public health problem associated with functional cobalamin (B12) deficiency and severe neurological complications. Despite growing recognition of its harms, the dose–response relationship and clinical value of biomarkers remain unclear.
Laxna Bhujel, Angela L. Chiew, Bhashita Jagarlamudi, Pramod Chandru, Naren Gunja, Nancy Briggs, Betty S. Chan   +6 more
wiley   +1 more source